Advertisement

Rökan pp 11-16 | Cite as

Dementias — A Growing Social and Medical Problem

  • E. W. Fünfgeld
Conference paper

Abstract

The expectation of life has risen constantly in most of the industrialized countries in the last 80 years. It was shown that the over 65 year-old US-population has grown from 3 millions in 1900 to more than 27 millions in 1984. About 6% of these persons suffered from Alzheimer’s disease. This group of illnesses increases with age — about 20–25% of people aged 85 years will be affected — actually more than 2 millions; in 65 years time this number will have increased to 16 million persons (G.D. Cohen 1986). B.E. Tomlinson (1986) pointed out that a world-wide collaboration and the search of subgroups with detailed analysis of cases — early onset or late onset — is required. Among the multiple aetiological factors, dementia caused by ischaemic lesions must be separated from dementias of other origin. “Our thinking about Alzheimer’s disease is too restricted if we assume that chemical and neuropathological findings and aetiology have to be identical and consistent from case to case” (Tomlinson). Davison (1982) pointed out that “functional deficits are greater than they would be expected from the neuropathological changes”.

Keywords

Senile Dementia Ginkgo Extract Normobaric Hypoxia Ginkgo Biloba Extract Ischaemic Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Amaducci, L., Schoenberg, B.S.: Analytic Epidemiology and Risk Factors in Alzheimer’s disease. In: Neurology, Proceed. XIIIth World Congress Neurol. K. Poeck, H.J. Freund and H. Gänshirt, p. 85–91. Springer-Verlag, BerlinHeidelberg-New York-Tokyo 1986.Google Scholar
  2. 2.
    Bagne, C.A., Pomara, N., Crook, T., Gershon, S.: Alzheimer’ s Disease: Strategies for treatment and research. In: Treatment development strategies for Alzheimer’s Disease, T. Crook, R. Bartus, S. Ferris, S. Gershon, p. 585–636. MarkPawley Ass, Madison, Conn. 1986.Google Scholar
  3. 3.
    Banks, W.A., Kastin, A.J.: Aging, peptides and the blood-brain barrier: Implications and spectulations. In: Treatment development strategies for Alzheimer’s Disease, T. Crook, R. Bartus, S. Ferris, S. Gershon, p. 245–266. Mark Pawley Ass, Madison, Conn. 1986.Google Scholar
  4. 4.
    Bloom, F.E.: Molecular diversity and neuronal function. In: Molecular aspects of neurobiology, R.L. Montalcene, P. Calissano, E.R. Kandel, A. Maggi, p. 188–192. Springer-Verlag, Berlin-Heidelberg-NewYork-Tokyo 1986.Google Scholar
  5. 5.
    Bowen, D.M., and Davison, A.N.: Can the Pathophysiology of Dementia Lead to Rational Therapy? In: Treatment Development Strategies for Alzheimer’s Disease, T. Crook, R. Bartus, S. Ferris, S. Gershon, p. 34–66. Mark Pawley Ass, Madison, Conn., 1986.Google Scholar
  6. 6.
    Calderini, G., Bonetti AC, Battistella A. et al.: Biochemical Changes of Rat Brain Membranes with Aging. Neurochernical Res. 18: 483–92 (1983).CrossRefGoogle Scholar
  7. 7.
    Cohen, G.D.: Foreword. In: Treatment Development Strategies for Alzheimer’s Disease, T. Crook, R. Bartus, S. Ferris, S. Gershon. Mark Pawley Ass, Madison, Conn., 1986.Google Scholar
  8. 8.
    Constantinidis, J.: Genetics of Vascular and Degenerative Dementias: The Geneva Studies. In: Modem Approaches to the Dementias, ed. F.C. Rose–Interdiscipl. Topics Geront., vol. 19, pp. 1–11, KArger, Basel 1985.Google Scholar
  9. 9.
    Davison, A.N.: Dementia. In: Disorders of Neurohumoral Transmission, ed. T.J. Crow, p. 341–369. London, New York etc. Academic Press 1982.Google Scholar
  10. 10.
    Fünfgeld, E.W.: Neue therapeutische Möglichkeiten für Parkinson-Patienten. Praxis-Kurier 25, Nr. 37, 25–28 (1987).Google Scholar
  11. 11.
    Fünfgeld, E.W.: Editorial: Multitherapie der Parkinson-Krankheit und der senilen Demenz vom Alzheimer Typ. Therapiewoche 37, 4521–4522 (1987).Google Scholar
  12. 12.
    Fünfgeld, E.W., Stalleicken, D.: Dynamic-Brain-Mapping. TW Neurol.Psychiatr. 2, 136–142 (1987).Google Scholar
  13. 13.
    Heiss, W.D., Pawlik, G., Herholz, K., Szelies, B., Beil, C., Wienhard, K.: Investigation of Regional Cerebral Blood Flow and Metabolism in Dementia. In: Senile Dementia of the Alzheimer Type, J. Traber and W.H. Gispen, p. 134–147. Springer-Verlag, Berlin-Heidelberg-New York-Tokyo 1985.Google Scholar
  14. 14.
    Hershkowitz, M.: Mechanisms of Brain Ageing - The Role of Membrane Fluidity. In: Aging of the Brain, W.H. Gispen and J. Traber, p. 85–99. Elsevier, Amsterdam-New York-Oxford 1983.Google Scholar
  15. 15.
    Hoyer, S.: Circulation and Oxidative Metabolism in the Normally and Abnormally Aging Brain. In: Aging of the Brain, W.H. Gispen and J. Traber, p. 151–165. Elsevier, Amsterdam-New York-Oxford 1983.Google Scholar
  16. 16.
    Itil, T.M., Shapiro, D.M., Eralp, E., Akman, A., Itil, K.Z., Garbizu, C.: A new Brain Function Diagnostic Unit, Including the Dynamic Brain Mapping of Computer Analyzed EEG, Evoked Potentials and Sleep (a new Hardware/Soft-ware System and its Application in Psychiatry and Psychopharmacology). New trends in exp. and clin. psychiat. 1,107–177 (1985) — Basic Publication —.Google Scholar
  17. 17.
    Krüger, G., Haubitz, I. and Hoyer, S.: Organic Psychiatric Disease in Young Adults and Aged Patients. In: The Aging Brain — Exper. Brain Research Supp. 5, ed. S. Hover, p. 236–242. Springer-Verlag, Berlin-Heidelberg-New York 1982.Google Scholar
  18. 18.
    Montarolo, P., Schacher, S., Castelucci, V.F., Hawkins, R.D., Abrams, T.W., Goelet, P., Kandel, E.R.: Interrelationships of cellular mechanism for different forms of learning and memory. In: Molecular aspects of neurobiology, R.L. Montalcene, P. Calissano, E.R. Kandel, A. Maggi. p. 1–14. Springer-Verlag, Berlin-Heidelberg-New York 1986.Google Scholar
  19. 19.
    Sapolsky, M., and McEwen, B.S.: Stress, Glucocorticoids, and Their Role in Degenerative Changes in the Aging Hippocampus. In: Treatment Development Strategies for Alzheimer’s Disease,eds. T. Crook, R. Bartus, S. Ferris, S. Gershon, p. 150–171. Mark Pawley Ass, Madison, Conn. 1986.Google Scholar
  20. 20.
    Sun, A., Sun, G.Y.: Neurochemical Aspects of the Membrane Hypothesis of Aging. In: Interdisciplinary Topics in Gerontology. 15: CNS Aging and Its Neuropharmacology, ed. W. Meier-Ruge, p. 34–53, Karger, Basel 1979.Google Scholar
  21. 21.
    Tomlinson, B.E.: The Dementias: A view to the future. In: Neurology, Proceed. XIIIth World Congress Neurol. K. Poeck, H.J. Freund and H. Gänshirt, p. 131–137. Springer-Verlag, Berlin-Heidelberg-New York-Tokyo 1986.Google Scholar
  22. 22.
    Vogt, O., Vogt, C.: Sitz und Wesen der Krankheiten im Lichte der topistischen Hirnforschung und des Variierens der Tiere. J.A. Barth, Leipzig 1937 und 1938.Google Scholar
  23. 23.
    Whalley, L.J., Wright, A.F., and Clair, D.M. St.: Genetic Factors in Down’s Syndrome and Their Possible Role in the Pathogenesis of Alzheimer’s Disease. In: Modern Approaches to the Dementias, ed. F.C. Rose — Interdiscipl. Topics Geront., vol. 19. pp. 18–31. Karger, Basel 1985.Google Scholar
  24. 24.
    Whitehouse, P.J., Au, K.S.: Neurotransmitter receptor alterations in Alzheimer’s disease. In: Senile Dementia of the Alzheimer Type, J. Traber, W.H. Gispen, p. 175–182. Springer-Verlag, Berlin-Heidelberg-New York-Tokyo 1985.Google Scholar
  25. 25.
    Winblad, B.G., Bucht, G., Fowler, C.J., Wallace, W.: Beyond the transmitter-based approach to Alzheimer’s Disease. In: Treatment Development Strategies for Alzheimer’s Disease, eds. T. Crook, R. Bartus, S. Ferris, S. Gershon, p. 67–97. Mark Pawley Ass, Madison, Conn. 1986.Google Scholar
  26. 26.
    Wisniewski, H., Merz, G.S., and Carp., R.I.: Current Hypothesis of the Etiology and Pathogenesis of Senile Dementia of the Alzheimer Type. In: Modern Approaches to the Dementias, ed. F.C. Rose — Interdiscipl. Topics Geront., vol. 19, pp. 18–31. Karger, Basel 1985.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg New York 1988

Authors and Affiliations

  • E. W. Fünfgeld
    • 1
  1. 1.Schloßbergklinik WittgensteinBad LaaspheGermany

Personalised recommendations